Trials / Conditions / Myasthenia Gravis, MuSK
Myasthenia Gravis, MuSK
3 registered clinical trials studyying Myasthenia Gravis, MuSK — 2 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | Safety and Efficacy of 3 Dose Levels of NMD670 in Adult Patients With Myasthenia Gravis NCT06414954 | NMD Pharma A/S | Phase 2 |
| Terminated | Long Term Safety Study of Amifampridine Phosphate in MuSK-MG (Muscle Specific Tyrosine Kinase Myasthenia Gravi NCT03579966 | Catalyst Pharmaceuticals, Inc. | Phase 3 |
| Recruiting | Myasthenia Gravis Foundation of America Global MG Patient Registry NCT06617741 | Myasthenia Gravis Foundation of America | — |